EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review

Aernoud P Bavinck, Waander van Heerde, Saskia E M Schols

Seminars in Thrombosis and Hemostasis · 01.07.2025 · 51 (05) · 541-559

DOI: 10.1055/s-0044-1787976 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Seminars in Thrombosis and Hemostasis, erschienen am 01.07.2025. Verfasst von Aernoud P Bavinck und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Point-of-Care Testing, Hemostasis, Blood Coagulation Disorders, Inherited. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inherited disorders of primary hemostasis, such as von Willebrand disease and congenital platelet disorders, can cause extensive, typically mucocutaneous bleeding. Assays to diagnose and monitor these disorders, such as von Willebrand factor activity assays and light transmission aggregometry, are performed in specialized hemostasis laboratories but are commonly not available in local hospitals. Due to the complexity and relative scarcity of these conventional assays, point-of-care tests (POCT) might be an attractive alternative in patients with hereditary bleeding disorders. POCTs, such as thromboelastography, are increasingly used to assess hemostasis in patients with acquired hemostatic defects, aiding clinical decision-making in critical situations, such as during surgery or childbirth. In comparison, the use of these assays in patients with hereditary hemostasis defects remains relatively unexplored. This review aims to give an overview of point-of-care hemostasis tests in patients with hereditary disorders of primary hemostasis. A summary of the literature reporting on the performance of currently available and experimental POCTs in these disorders is given, and the potential utility of the assays in various use scenarios is discussed. Altogether, the studies included in this review reveal that several POCTs are capable of identifying and monitoring severe defects in the primary hemostasis, while a POCT that can reliably detect milder defects of primary hemostasis is currently lacking. A better understanding of the strengths and limitations of POCTs in assessing hereditary defects of primary hemostasis is needed, after which these tests may become available for clinical practice, potentially targeting a large group of patients with milder defects of primary hemostasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Point-of-Care TestingHemostasisBlood Coagulation Disorders, InheritedHumans

Autor:innen und Institutionen

  • Department of Hematology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Department of Hematology, Radboud University Medical Centre, Hemophilia Treatment Centre Nijmegen-Eindhoven-Maastricht, Nijmegen, The Netherlands.

Zitieren

APA

Bavinck, A. P., Heerde, W. V., & Schols, S. E. M. (2025). Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review. Seminars in Thrombosis and Hemostasis, 51(05), 541-559. https://doi.org/10.1055/s-0044-1787976

Vancouver

Bavinck AP, Heerde WV, Schols SEM. Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review. Seminars in Thrombosis and Hemostasis. 2025;51(05):541-559. doi:10.1055/s-0044-1787976

BibTeX
@article{Bavinck2025,
  author = {Bavinck, Aernoud P and Heerde, Waander van and Schols, Saskia E M},
  title = {Point-of-Care Testing in Patients with Hereditary Disorders of Primary Hemostasis: A Narrative Review},
  journal = {Seminars in Thrombosis and Hemostasis},
  year = {2025},
  volume = {51},
  number = {05},
  pages = {541--559},
  doi = {10.1055/s-0044-1787976}
}
Kostenlos starten →